Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 10,351 shares of Cardlytics stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $2.71, for a total value of $28,051.21. Following the completion of the sale, the chief executive officer directly owned 146,288 shares of the company’s stock, valued at approximately $396,440.48. The trade was a 6.61% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.
Amit Gupta also recently made the following trade(s):
- On Friday, October 2nd, Amit Gupta sold 7,382 shares of Cardlytics stock. The shares were sold at an average price of $2.53, for a total transaction of $18,676.46.
- On Tuesday, August 18th, Amit Gupta sold 6,676 shares of Cardlytics stock. The stock was sold at an average price of $4.03, for a total value of $26,904.28.
- On Monday, August 17th, Amit Gupta sold 6,785 shares of Cardlytics stock. The shares were sold at an average price of $3.97, for a total transaction of $26,936.45.
- On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total value of $42,319.60.
Cardlytics Price Performance
Shares of CDLX stock opened at $2.53 on Monday. The company’s fifty day simple moving average is $3.81 and its two-hundred day simple moving average is $5.86. Cardlytics, Inc. has a 52 week low of $2.47 and a 52 week high of $26.70. The stock has a market cap of $14.70 million, a P/E ratio of -0.14 and a beta of 0.70.
Analyst Upgrades and Downgrades
CDLX has been the topic of a number of analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research note on Thursday, June 18th. Weiss Ratings reissued a “sell (e+)” rating on shares of Cardlytics in a research note on Wednesday, July 8th. Finally, Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, September 19th. One investment analyst has rated the stock with a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Cardlytics presently has an average rating of “Sell” and a consensus price target of $10.00.
Check Out Our Latest Stock Report on Cardlytics
Hedge Funds Weigh In On Cardlytics
An institutional investor recently bought a new stake in Cardlytics stock. Worldly Partners Management LLC purchased a new position in Cardlytics, Inc. (NASDAQ:CDLX – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 115,798 shares of the company’s stock, valued at approximately $520,000. Cardlytics makes up approximately 0.4% of Worldly Partners Management LLC’s portfolio, making the stock its 3rd largest holding. Worldly Partners Management LLC owned 1.99% of Cardlytics at the end of the most recent quarter. 68.10% of the stock is owned by institutional investors.
Cardlytics Company Profile
Cardlytics, Inc is an advertising technology company that connects marketers with consumers through financial institutions. Its platform uses transaction-based insights to help advertisers reach customers with relevant offers and measure the impact of advertising on consumer spending.
Cardlytics’ services are integrated into banking and financial applications, where consumers may receive personalized cash-back offers, discounts and other promotions based on their shopping activity. Participating financial institutions can use the platform to provide additional value to customers while generating advertising revenue.
The company serves advertisers across categories such as retail, dining, travel and financial services, and works with banks and other financial institutions primarily in the United States and the United Kingdom.
Further Reading
- Five stocks we like better than Cardlytics
- Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?
- The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It
- McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers?
- MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
